1. Home
  2. TRSG vs GBIO Comparison

TRSG vs GBIO Comparison

Compare TRSG & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRSG
  • GBIO
  • Stock Information
  • Founded
  • TRSG 1996
  • GBIO 2016
  • Country
  • TRSG Singapore
  • GBIO United States
  • Employees
  • TRSG N/A
  • GBIO N/A
  • Industry
  • TRSG
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRSG
  • GBIO Health Care
  • Exchange
  • TRSG NYSE
  • GBIO Nasdaq
  • Market Cap
  • TRSG 27.0M
  • GBIO 29.2M
  • IPO Year
  • TRSG 2024
  • GBIO 2020
  • Fundamental
  • Price
  • TRSG $1.60
  • GBIO $0.52
  • Analyst Decision
  • TRSG
  • GBIO Strong Buy
  • Analyst Count
  • TRSG 0
  • GBIO 4
  • Target Price
  • TRSG N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • TRSG 4.8K
  • GBIO 1.8M
  • Earning Date
  • TRSG 05-14-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • TRSG N/A
  • GBIO N/A
  • EPS Growth
  • TRSG N/A
  • GBIO N/A
  • EPS
  • TRSG N/A
  • GBIO N/A
  • Revenue
  • TRSG $12,810,249.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • TRSG N/A
  • GBIO N/A
  • Revenue Next Year
  • TRSG N/A
  • GBIO N/A
  • P/E Ratio
  • TRSG N/A
  • GBIO N/A
  • Revenue Growth
  • TRSG N/A
  • GBIO 146.47
  • 52 Week Low
  • TRSG $1.00
  • GBIO $0.30
  • 52 Week High
  • TRSG $4.57
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • TRSG N/A
  • GBIO 66.42
  • Support Level
  • TRSG N/A
  • GBIO $0.32
  • Resistance Level
  • TRSG N/A
  • GBIO $0.59
  • Average True Range (ATR)
  • TRSG 0.00
  • GBIO 0.05
  • MACD
  • TRSG 0.00
  • GBIO 0.02
  • Stochastic Oscillator
  • TRSG 0.00
  • GBIO 76.34

About TRSG TUNGRAY TECHNOLOGIES INC

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: